Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $48 from $45 and keeps an Overweight rating on the shares after updating the firm’s estimates to reflect Q2 earnings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $47 from $42 at Scotiabank
- American Healthcare REIT price target raised to $46 from $44 at Truist
- American Healthcare REIT price target raised to $44 from $38 at Truist
- American Healthcare REIT price target raised to $45 from $39 at RBC Capital
- American Healthcare REIT Reports Strong Earnings Call